Table 1.

Demographic, clinical and pathological datas from three groups

	Group 1	Group 2	Group 3	p value
Age	64.2 ±4.1	63.7 ±4.6	65.2 ±4.2	0.501
PSA (ng/ml)	8.64 ±3.2	7.37 ±2.9	9.65 ±3	0.353
Prostate
volume (ml)	48.93 ±11.1	54.4 ±8.6	51.5 ±9.1	0.446
Cancer	8/31	8/31	9/31
detection rate (%)	(25.8%)	(25.8%)	(29.03%)	0.948
Gleason score (mean)	6.8 ±0.8	7.2 ±0.9	7.12 ±0.8	0.654
Fever	1/31 (3.22%)	1/31 (3.22%)	0	0.982
Gross rectal bleeding	0	0	0
Gross Hematuria	0	0	0
Low degree macroscopichematuria	7 (22.5%)	4 (12.9%)	2 (6.4%)	0.027

PSA – prostate specific antigen